ARCHIVES

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

This article is from The Cancer Letter archive.

Vol. 22 No. 21 | May 24, 1996

Download PDF Visit The Full Archive

Related Articles

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

Breast Cancer Strategic Plan Underway Following HHS Secretary’s Conference

January 7, 1994

Holden Center At U. Of Iowa Designated Comprehensive.

January 26, 2001

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

In Brief: Charles Smart To Give Up Commission On Cancer Post, Kansas Surgeon To Become Fulltime Director

April 15, 1983